Literature DB >> 1686899

Amyotrophic lateral sclerosis: glutamate dehydrogenase and transmitter amino acids in the spinal cord.

S Malessa1, P N Leigh, O Bertel, E Sluga, O Hornykiewicz.   

Abstract

Measurements were taken of the activity of glutamate dehydrogenase (GDH) and the levels of transmitter amino acids in anatomically dissected regions of cervical and lumbar spinal cord in eight patients dying with amyotrophic lateral sclerosis (ALS) and in 11 neurologically normal controls. GDH activity was considerably increased in lateral and ventral white matter and in the dorsal horn of the ALS cervical spinal cord, but normal in the ventral horn and the dorsal columns. Similar, although less pronounced, GDH changes were found in the lumbar enlargement. The mean concentrations of aspartate and glutamate were reduced in all regions of ALS spinal cord investigated. Taurine concentrations were significantly increased in several subdivisions of cervical spinal cord, but normal in lumbar regions. Glycine levels were significantly reduced in lumbar ventral and dorsal horns. There was no striking change in spinal cord GABA levels in our ALS patients. It is suggested that the reduced levels of glutamate and aspartate as well as the elevated GDH activity in the spinal cord of ALS patients may reflect an overactivity of the neurons releasing these potentially excitotoxic amino acids and thus may be causally related to the spinal neuro-degenerative changes characteristic of ALS.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1686899      PMCID: PMC1014621          DOI: 10.1136/jnnp.54.11.984

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  25 in total

1.  The purification and properties of rat brain glutamate dehydrogenase.

Authors:  P Y Chee; J L Dahl; L A Fahien
Journal:  J Neurochem       Date:  1979-07       Impact factor: 5.372

2.  Oxidative histochemistry of reactive astrocytes.

Authors:  K A OSTERBERG; L W WATTENBERG
Journal:  Arch Neurol       Date:  1962-09

3.  Free amino acids in motor cortex of amyotrophic lateral sclerosis.

Authors:  Y Yoshino; H Koike; K Akai
Journal:  Experientia       Date:  1979-02-15

4.  Glutamate dehydrogenase and aspartate aminotransferase in leukocytes of patients with motor neuron disease.

Authors:  J Hugon; F Tabaraud; M Rigaud; J M Vallat; M Dumas
Journal:  Neurology       Date:  1989-07       Impact factor: 9.910

5.  Muscarinic inhibition of endogenous glutamate release from rat hippocampus synaptosomes.

Authors:  M Marchi; P Bocchieri; L Garbarino; M Raiteri
Journal:  Neurosci Lett       Date:  1989-01-16       Impact factor: 3.046

6.  Chemical changes in the spinal cord in Friedreich's ataxia and motor neurone disease.

Authors:  N Robinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1968-08       Impact factor: 10.154

7.  Low leukocyte glutamate dehydrogenase activity does not correlate with a particular type of multiple system atrophy.

Authors:  R C Duvoisin; W J Nicklas; V Ritchie; J Sage; S Chokroverty
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-12       Impact factor: 10.154

8.  Postmortem changes of amino compounds in human and rat brain.

Authors:  T L Perry; S Hansen; S S Gandham
Journal:  J Neurochem       Date:  1981-02       Impact factor: 5.372

9.  Leukocyte glutamate dehydrogenase activity in patients with degenerative neurological disorders.

Authors:  D Aubby; H K Saggu; P Jenner; N P Quinn; A E Harding; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-07       Impact factor: 10.154

10.  Glutamate dehydrogenase in olivopontocerebellar atrophies: leukocytes, fibroblasts, and muscle mitochondria.

Authors:  G Finocchiaro; F Taroni; S Di Donato
Journal:  Neurology       Date:  1986-04       Impact factor: 9.910

View more
  9 in total

Review 1.  Inhibitory synaptic regulation of motoneurons: a new target of disease mechanisms in amyotrophic lateral sclerosis.

Authors:  Lee J Martin; Qing Chang
Journal:  Mol Neurobiol       Date:  2011-11-10       Impact factor: 5.590

2.  Glycine receptor channels in spinal motoneurons are abnormal in a transgenic mouse model of amyotrophic lateral sclerosis.

Authors:  Qing Chang; Lee J Martin
Journal:  J Neurosci       Date:  2011-02-23       Impact factor: 6.167

3.  miR-338-3p is over-expressed in blood, CFS, serum and spinal cord from sporadic amyotrophic lateral sclerosis patients.

Authors:  Bruna De Felice; Anna Annunziata; Giuseppe Fiorentino; Marco Borra; Elio Biffali; Cinzia Coppola; Roberto Cotrufo; Johannes Brettschneider; Maria Luisa Giordana; Tamas Dalmay; Guy Wheeler; Raffaella D'Alessandro
Journal:  Neurogenetics       Date:  2014-08-19       Impact factor: 2.660

4.  Plasma taurine is an axonal excitability-translatable biomarker for amyotrophic lateral sclerosis.

Authors:  Tomoko Nakazato; Kazuaki Kanai; Tetsushi Kataura; Shuko Nojiri; Nobutaka Hattori; Shinji Saiki
Journal:  Sci Rep       Date:  2022-06-01       Impact factor: 4.996

5.  Abnormal glycine metabolism in motor neurone disease: studies on plasma and cerebrospinal fluid.

Authors:  R J Lane; R Bandopadhyay; J de Belleroche
Journal:  J R Soc Med       Date:  1993-09       Impact factor: 5.344

6.  Glycinergic innervation of motoneurons is deficient in amyotrophic lateral sclerosis mice: a quantitative confocal analysis.

Authors:  Qing Chang; Lee J Martin
Journal:  Am J Pathol       Date:  2008-12-30       Impact factor: 4.307

7.  Disruption of TCA Cycle and Glutamate Metabolism Identified by Metabolomics in an In Vitro Model of Amyotrophic Lateral Sclerosis.

Authors:  Charlotte Veyrat-Durebex; Philippe Corcia; Eric Piver; David Devos; Audrey Dangoumau; Flore Gouel; Patrick Vourc'h; Patrick Emond; Frédéric Laumonnier; Lydie Nadal-Desbarats; Paul H Gordon; Christian R Andres; Hélène Blasco
Journal:  Mol Neurobiol       Date:  2015-12-14       Impact factor: 5.590

Review 8.  ALS Patient Stem Cells for Unveiling Disease Signatures of Motoneuron Susceptibility: Perspectives on the Deadly Mitochondria, ER Stress and Calcium Triad.

Authors:  Anjoscha Kaus; Dhruv Sareen
Journal:  Front Cell Neurosci       Date:  2015-11-19       Impact factor: 5.505

Review 9.  ALS and oxidative stress: the neurovascular scenario.

Authors:  Akshay Anand; Keshav Thakur; Pawan Kumar Gupta
Journal:  Oxid Med Cell Longev       Date:  2013-12-03       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.